Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.
Now here’s the best of what YOU had to say:
Genomics – a revolution in medicine: Part 1. In the coming years we can expect to learn about new drugs developed using genomic approaches as with Gleevec and Herceptin; tests to advise the doctor as to what drugs will or will not work in a given patient and many new tests to prevent a patient from having an unwarranted side effect. Such is the power of genomics for the future; it will indeed be a revolution.
An omic vision of a diagnostic/prognostic future. An article by Chen et al., published recently in the journal Cell, offers us what Eric Topol has already dubbed “panor-omic” insight into a potential future – one in which our genomic data can be cross-correlated against other “omic” data (including transcriptomic, proteomic, metabolomic, and autoantibody profiles) to give individualized insights into our current clinical disorders and our risks for future disorders.
Latest expansion of Medicaid is smaller than previous growth during Bush. Taking the recession’s impact and reform together, the Obama years’ Medicaid expansion (assuming the president and reform survive) will come to about 26 percent, higher than the Clinton years, no doubt, but significantly smaller than the increases experienced under either of the Bushes.
AdvaMed 2012 call for company presentations now open. As of April 3, Abbott, Covidien, Ernst & Young and Kaplan EduNeering have signed up as host sponsors of AdvaMed 2012, along with 25 others providing support at varying levels.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.